Vaccines

04 Sep 2019 Janssen Announces U.S. FDA Breakthrough Therapy Designation for Investigational Prophylactic Vaccine for the Prevention of Respiratory Syncytial Virus in Older Adults
27 Aug 2019 Imcyse reports successful first-in-human Phase 1b study in type 1 diabetes with IMCY-0098
22 Aug 2019 Themis Bioscience Announces Exclusive License and Research Collaboration Agreement with MSD to Develop Vaccine Candidates
21 Aug 2019 Aimmune Enrolls First Patient in Phase 2 Trial of AR201 for Egg Allergy
20 Aug 2019 Tonix Pharmaceuticals Expands Preclinical Pipeline with Triple Reuptake Inhibitor, TNX-1600, for the Treatment of PTSD
20 Aug 2019 Vaxxilon Awarded CARB-X Grant to Advance Novel Prophylactic Vaccine to Prevent Klebsiella pneumoniae Infections
19 Aug 2019 ActoBio Therapeutics™ Receives IND Green Light for New Antigen-Specific Immunotherapy Study Aimed at Improving Celiac Patients' Tolerance of Gluten
19 Aug 2019 Inovio Completes Enrollment of its VGX-3100 Open-label Phase 2 Trial for Treatment of HPV-Related High-Grade Anal Dysplasia
14 Aug 2019 Gritstone Oncology Announces First Patient Dosed with SLATE, its “Off-The-Shelf” Neoantigen Immunotherapy
14 Aug 2019 Brain Cancer Patients Display Decreasing Tumor Biomarkers After Treatment with Novel Immunotherapy in AIVITA Biomedical's Phase 2 Clinical Trial
06 Aug 2019 Transfer from GSK and partnership with NIAID will enable Sabin to advance development of the candidate vaccines
05 Aug 2019 Lilly Announces Positive Results for Emgality® (galcanezumab-gnlm) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments
05 Aug 2019 SELLAS Announces Completion of Enrollment in Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In Situ (DCIS) of the Breast
31 Jul 2019 SELLAS Advances Galinpepimut-S (GPS) in Combination with KEYTRUDA® (pembrolizumab) Program with Dosing of First Patient in Phase 1/2 Basket Study
30 Jul 2019 New Startup Biotech Company Plans to Test Promising Herpes Vaccine for Both HSV-1 and HSV-2
29 Jul 2019 Inovio’s Cancer Immunotherapy (INO-5151) Targeting Prostate Cancer in Innovative Cancer Combination Trial
23 Jul 2019 ViiV Healthcare presents positive 96-week data from phase III study of investigational fostemsavir in heavily treatment-experienced patients with HIV at IAS 2019
17 Jul 2019 Elios Therapeutics Announces Positive Top-Line Data from Phase IIb Study Evaluating TLPLDC, a Personalized Therapeutic Cancer Vaccine, in Patients with High-Risk Melanoma
17 Jul 2019 Inovio Sharpens Focus On HPV-Related Diseases And Fast-to-Market Product Candidates
15 Jul 2019 New Immune Data from Ongoing ADXS-NEO Phase 1 Study Support Clinical Potential for Neoantigen-Directed Immunotherapies
15 Jul 2019 Neon Therapeutics’ Personal Neoantigen Vaccine Study Demonstrates Prolonged Progression-Free Survival in Advanced or Metastatic Melanoma, Non-Small Cell Lung and Bladder Cancers
12 Jul 2019 HOOKIPA Announces FDA Clearance of IND Application for HB-201 Clinical Trial to Treat HPV-Positive Cancers
11 Jul 2019 Transgene Receives MHRA Approval for Lead myvac™ Individualized Immunotherapy, TG4050, to Commence Clinical Development in HPV Negative Head and Neck Cancers in the UK
09 Jul 2019 Vaxart Enters into Research Collaboration with Janssen to Evaluate Oral Universal Influenza Vaccine
27 Jun 2019 Advaxis Announces Increasing Focus on Neoantigen-Directed Immunotherapies and Closing of Its Phase 3 AIM2CERV Study

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top